Intracellular Trafficking Considerations in the Development of Natural Ligand-Drug Molecular Conjugates for Cancer

Annals of Biomedical Engineering - Netherlands
doi 10.1007/s10439-011-0280-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2014English

Poly(amidoamine) Dendrimer–drug Conjugates With Disulfide Linkages for Intracellular Drug Delivery

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2009English

Molecular Imaging in Cancer Drug Development

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2018English

Regulatory Considerations on Endpoints in Ovarian Cancer Drug Development

Cancer
Cancer ResearchOncology
2017English

Antibody-Drug Conjugates in Bladder Cancer

Bladder Cancer
OncologyUrology
2018English

Site-Specific Antibody Drug Conjugates for Cancer Therapy

mAbs
AllergyImmunology
2013English

Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2018English

Intracellular Cholesterol Trafficking

1998English

AKT in Cancer: New Molecular Insights and Advances in Drug Development

British Journal of Clinical Pharmacology
Pharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy